Crewe Advisors’s Aveanna Healthcare AVAH Stock Holding History

Crewe Advisors’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-282	Closed	–	–	1037
2022 Q3	$0	Hold	282	–	–	﹤0.01%	1244
2022 Q2	$1K	Buy	+282	New	+$818	﹤0.01%	1041

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $233M AUM 18.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Crewe Advisors's AVAH Position: Q4 2022 in Review

Crewe Advisors sold out of Aveanna Healthcare (AVAH) in Q4 2022, closing a stake of 282 shares.

Crewe Advisors first reported a position in AVAH in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 82 funds tracked by Wall St. Rank hold AVAH as of Q4 2022.

Crewe Advisors reported no remaining Aveanna Healthcare position as of Q4 2022 after selling out during the quarter.
Crewe Advisors sold 282 Aveanna Healthcare shares in Q4 2022.
Crewe Advisors first reported a position in Aveanna Healthcare in Q2 2022 and held it in 2 quarters.
Crewe Advisors's Aveanna Healthcare position peaked at $1K in Q2 2022.
82 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.